295PExploratory biomarker analysis in patients treated with vinorelbine plus everolimus or vinorelbine monotherapy as second-line treatment for HER2-negative advanced breast cancer: Final results from the randomized phase II trial VicTORia. (23rd October 2018) - Decker, T; Mündlein, A; Marschner, N; Welt, A; Riedt, T; Hagen, V; Rauh, J; Klein, D; Potthoff, K; Jähnig, P; Schröder, H; Hegewisch-Becker, S; et al.